Chemo injection before surgery for recurrent throat cancer
Treatments studied
Part of Cancer clinical trials.
This trial tests injecting a chemotherapy drug (cisplatin with epinephrine) directly into throat tumors, given once a week for 3 weeks before planned surgery. It is for people whose throat cancer has come back after radiation and who need surgery to remove it.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You had radiation therapy for laryngeal (voice box) cancer in the past.
- Your throat cancer has come back, proven by biopsy, and you need surgery.
- You are willing to get 3 weekly injections of the study drug while awake (a mild sedative is allowed).
- You have adequate kidney, liver, and blood cell counts tested within the past 6 weeks.
- You agree to avoid pregnancy for the study duration and 14 months after the last dose.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a combination of immunotherapy and chemotherapy before surgery can help people whose throat cancer has come back after treatment. The goal is to shrink the tumor before surgery, which may improve outcomes.
This trial tests whether giving a combination of an immunotherapy drug (PD-1 inhibitor) and chemotherapy before surgery can help treat advanced throat cancer. The goal is to see if this approach shrinks tumors and improves outcomes.
This trial tests whether adding an immunotherapy drug (PD-1 inhibitor) to standard chemotherapy before surgery improves outcomes for people with advanced laryngeal or hypopharyngeal cancer. The treatment is given before your planned total laryngectomy, and the goal is to shrink the tumor and potentially improve long-term results.
This trial tests a new combination of an immunotherapy drug (adebrelimab) with chemotherapy before surgery, to shrink the cancer and improve outcomes for patients with advanced hypopharyngeal cancer. It may help make surgery more effective and reduce the chance of the cancer coming back.
This trial tests a new approach to treat throat cancer while trying to preserve your larynx (voice box). It combines chemotherapy drugs and an immunotherapy drug before surgery or radiation. The goal is to see if this can help you avoid needing to have your larynx removed.
This trial tests whether adding immunotherapy before surgery, followed by either radiation or organ-preserving surgery, can improve outcomes for people with locally advanced laryngeal or hypopharyngeal cancer. It may help avoid complete removal of the voice box.
Hear when a new Laryngeal Squamous Cell Carcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.